Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma (mRCC) treated with targeted therapy: Results from the International mRCC Database Consortium.
Wanling Xie
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Jae-Lyun Lee
No relevant relationships to disclose
Lauren Christine Harshman
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech; Novartis
Georg A. Bjarnason
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer
Jennifer J. Knox
Consultant or Advisory Role - AVEO; Pfizer
Research Funding - Bayer; Novartis; Pfizer
Mary J. MacKenzie
No relevant relationships to disclose
Lori Wood
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - Novartis; Pfizer
Ulka N. Vaishampayan
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Takeshi Yuasa
No relevant relationships to disclose
Min-Han Tan
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Frede Donskov
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Christian K. Kollmannsberger
No relevant relationships to disclose
Scott A. North
No relevant relationships to disclose
Brian I. Rini
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; Novartis; Pfizer